Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Staphylococcus aureus subsp. aureus MSSA476, MSSA476

>SAS0696 ribonucleoside-diphosphate reductase alpha chain
MKTMEEKKYNHIELNNEVTKRREDGFFSLEKDQEALVAYLEEVKDKTIFF
DTEIERLRYLVDNDFYFNVFDIYSEADLIEITDYAKSIPFNFASYMSASK
FFKDYALKTNDKSQYLEDYNQHVAIVALYLANGNKAQAKQFISAMVEQRY
QPATPTFLNAGRARRGELVSCFLLEVDDSLNSINFIDSTAKQLSKIGGGV
AINLSKLRARGEAIKGIKGVAKGVLPIAKSLEGGFSYADQLGQRPGAGAV
YLNIFHYDVEEFLDTKKVNADEDLRLSTISTGLIVPSKFFDLAKEGKDFY
MFAPHTVKEEYGVTLDDIDLEKYYDDMVANPNVEKKKKNAREMLNLIAQT
QLQSGYPYLMFKDNANRVHPNSNIGQIKMSNLCTEIFQLQETSIINDYGI
EDEIKRDISCNLGSLNIVNVMESGKFRDSVHSGMDALTVVSDVANIQNAP
GVRKANSELHSVGLGVMNLHGYLAKNKIGYESEEAKDFANIFFMMMNFYS
IERSMEIAKERGIKYQDFEKSDYANGKYFEFYTTQEFEPQFEKVRELFDG
MAIPTSEDWKKLQQDVEQYGLYHAYRLAIAPTQSISYVQNATSSVMPIVD
QIERRTYGNAETFYPMPFLSPQTMWYYKSAFNTDQMKLIDLIATIQTHID
QGISTILYVNSEISTRELARLYVYAHYKGLKSLYYTRNKLLSVEECTSCS
I
>SAS0110 putative purine nucleoside phosphorylase
MKSTPHIKPMNDVEIAETVLLPGDPLRAKFIAETYLDDVEQFNTVRNMFG
FTGTYKGKKVSVMGSGMGMPSIGIYSYELIHTFGCKKLIRVGSCGAMQEN
IDLYDVIIAQGASTDSNYVQQYQLPGHFAPIASYQLLEKAVGTARDKGVR
HHVGNVLSSDIFYNADTTASERWMRMGILGVEMESAALYMNAIYAGVEAL
GVFTVSDHLIHETSTTPEERERAFTDMIEIALSLV
>SAS1000 putative phosphoribosylaminoimidazole carboxylase catalytic subunit
MKVAVIMGSSSDWKIMQESCNMLDYFEIPYEKQVVSAHRTPKMMVQFASE
ARERGINIIIAGAGGAAHLPGMVASLTTLPVIGVPIETKSLKGIDSLLSI
VQMPGGIPVATTAIGAAGAKNAGILAARMLSIQNPSLVEKLNQYESSLIQ
KVEDMQNELQ
>SAS1003 conserved hypothetical protein
MKTIELHITLQPQVLDTQGQTLTRAVHDLGYAQVNDIRVGKVLYMTVDEV
SDEKVHNIITTLSEKLFANTVIEEYSYKVLDDEKENA
>SAS1004 putative phosphoribosylformylglycinamidine synthase I
MKFAVLVFPGSNCDRDMFNAAIKSGVEAEYVDYRETSLSGFDGVLIPGGF
SFGDYLRSGAMASVAPIISEVKRLAAEGKPVLGVCNGFQILTEIGLLPGA
LLHNDSHLFISRNEELEIVNNQTAFTNLYEQGEKVIYPVAHGEGHYYCTD
EIYQQLKANNQIILKYVNNPNGSYDDIAGIVNKKGNVCGMMPHPERALET
LLGTDSGVKLFEAMVKSWREQHV
>SAS2503 anaerobic ribonucleoside-triphosphate reductase
MNQIEEALTGLISKDPAIVNENANKDSDTFSTMRDLTAGIVSKSYALNYL
LPKHVADAHQRGDIHFHDLDYHPFQPLTNCCLIDAKNMLHNGFEIGNANV
TSPKSIQTASAQLVQIIANVSSSQYGGCTVDRVDELLSTYARHNEEQHRN
IAKQFVKESEIDRYVDQQVTKDINDAIESLEYEINTLYTSNGQTPFVTLG
FGLGTDHLSRKIQQAILNTRIKGLGKDRTTAIFPKLVFSIKKGTNFSPQD
PNYDIKQLALKCSTKRMYPDILNYDKLVEILGDFKAPMGCRSFLPSWKDA
EGHFENNGRCNLGVVTLNLPRMALESAGNMTKFWEIFYERIDVLHDALLY
RINRLKDAVPNNAPILYKSGAFNYKLKETDDVAELFKNKRATISMGYIGL
YETATVFYGPDWETSQEAKAFTLEILKEMKRYQTKWTELYDIWFSIYSTP
SESLTDRFCRLDQERFGDIKDITDKGYYQNSFHYDVRKDVTPFEKLDFEK
DYPYYASGGFIHYCEYPKLQHNLKALEAVWDYSYDKVGYLGTNIPIDHCY
ECDYDGDFEATEKGFKCPNCGNDNPKTVDVVKRTCGYLGNPVQRPVIKGR
HKEICARVKHMKAPKE
>SAS0023 putative 5'-nucleotidase
MIIYWCMTVNGGNEMKALLLKTSVWLVLLFSVMGLWQVSNAAEQHTPMKA
HAVTTIDKATTDRQQVPPTKEAAHHYGEEAATNVSASAQGTADDTNNKVT
SNAPTNKPTTAVSTTGNKRHDVDAQQASTQKPTHTATFKLSNAKTASLSP
RMFAANVPQTTTHKILHTNDIHGRLAEEKGRVIGMAKLKTVKEQEKPDLM
LDAGDAFQGLPLSNQSKGEEMAKAMNAVGYDAMAVGNHEFDFGYDQLKKL
EGMLDFPMLSTNVYKDGKRAFKPSTIVTKNGIRYGIIGVTTPETKTKTRP
EGIKGVEFRDPLQSVTAEMMRIYKDVDTFVVISHLGIDPSTQETWRGDYL
VKQLSQNPQLKKRITVIDGHSHTVLQNGQIYNNDALVQTGTALANIGKIT
FNYRNGEVSNIKPSLINVKDVENVTPNKALAEQINQADQTFRAQTAEVII
PNNTIDFKGERDDVRTRETNLGNAIADAMEAYGVKNFSKKTDFAVTNGGG
IRASIAKGKVTRYDLISVLPFGNTIAQIDVKGSDVWTAFEHSLGAPTTQK
DGKTVLTANGGLLHISDSIRVYYDMNKPSGKRINAIQILNKETGKFESID
LKRVYHVTMNDFTASGGDGYSMFGGPREEGISLDQVLASYLKTANLAKYD
MTEPQRMLLGKPVASEQPAKGQQGSKGSESGKDTQPIGKEKVMNPAKQPA
TGKVVLLPAHRGTVSSGTEGSDRALEGTAVSSKSGKQLANMSAPKGSAHE
KQLPKTGTDQSSSPAAMFVLVTGIGLIATVRRRKAS
>SAS1143 putative guanylate kinase
MDNEKGLLIVLSGPSGVGKGTVRKRIFEDPSTSYKYSISMTTRQMREGEV
DGVDYFFKTRDAFEALIKDDQFIEYAEYVGNYYGTPVQYVKDTMDEGHDV
FLEIEVEGAKQVRKKFPDALFIFLAPPSLEHLRERLVGRGTESDEKIQSR
INEARKEVEMMNLYDYVVVNDEVELAKNRIQCIVEAEHLKRERVEAKYRK
MILEAKK
>SAS0364 putative xanthine phosphoribosyltransferase
MELLGQKVKEDGVVIDEKILKVDGFLNHQIDAKLMNEVGRTFYEQFKDKG
ITKILTIEASGIAPAIMAALHFDVPCLFAKKAKPSTLTDGYYETSIHSFT
KNKTSTVIVSKEFLSEEDTVLIIDDFLANGDASLGLYDIAQQANAKTAGI
GIVVEKSFQNGHQRLEEAGLTVSSLCKVASLEGNKVTLVGEE
>SAS1277 putative GMP reductase
MKIFDYEDIQLIPNKCIVESRSECDTTIQFGPKKFKLPVVPANMQTVMNE
KLAKWFAENDYFYIMHRFDEEARIPFIKHMQNSGLFASISVGVKKAEFDF
IEKLAQEKLIPEYITIDIAHGHSDSVINMIKHIKNHIPDSFVIAGNVGTP
EGVRELENAGADATKVGIGPGRVCITKIKTGFGTGGWQLAALNICSKAAR
KPLIADGGIRTHGDIAKSIRFGASMVMIGSLFAAHEESPGETVELDGKQY
KEYFGSASEFQKGEHKNVEGKKMFVEHKGSLMDTLKEMQQDLQSSISYAG
GKDLKSLRTVDYVIVRNSIFNGDRD
>SAS0457 ribose-phosphate pyrophosphokinase
MLNNEYKNSSLKIFSLKGNEALAQEVADQVGIELGKCSVKRFSDGEIQIN
IEESIRGCDVFIIQPTSYPVNLHLMELLIMIDACKRASAATINIVVPYYG
YARQDRKARSREPITAKLVANLIETAGATRMIALDLHAPQIQGFFDIPID
HLMGVPILAKHFKDDPNINPEECVVVSPDHGGVTRARKLADILKTPIAII
DKRRPRPNVAEVMNIVGEIEGRTAIIIDDIIDTAGTITLAAQALKDKGAK
EVYACCTHPVLSGPAKERIENSAIKELIVTNSIHLDEDRKPSNTKELSVA
GLIAQAIIRVYERESVSVLFD
>SAS0112 deoxyribose-phosphate aldolase
MKFEKYIDHTLLKPESTRTQIDQIIDEAKAYNFKSVCVNPTHVKYAAERL
ADSEVLVCTVIGFPLGASTTATKAFETEDAIQNGADEIDMVINIGALKDG
RFDDVQQDIEAVVKVAKGHTVKVIIETVLLDHDEIVKASELTKAAGADFV
KTSTGFAGGGATAEDVKLMKDTVGADVEVKASGGVRNLEDFNKMVEAGAT
RIGASAGVQIMQGLEADSDY
>SAS1759 HIT-family protein
MSETIFGKILTGEIPSFKVYEDDYVYAFLDISQVTKGHTLLIPKKASANI
FETDEETMKHIGAALPKVANAIKRAFNPDGLNIIQNNGEFADQSVFHIHF
HLIPRYENDIDGFGYKWETHEDILDNDAKQQIAEQIQAQF
>SAS0219 putative inosine-uridine preferring nucleoside hydrolase
MKRKIIMDCDPGHDDAIALILAGAIDSPLEILAVTTVAGNQSVDKNTTNA
LNVLDIMGRQDIAVAKGADRPLIKPAAFASEIHGESGLDGPKLPSTPSRQ
AVAMPASDVIINKVMTSDTPVTIVATGPLTNVATALIREPRIAEHIESIT
LMGGGTFGNWTPTAEFNIWVDAEAAKRVFESGITINVFGLDVTHQVLADD
HVIERFESINNPVAQFVVELLQFFKKTYKTHFNMDGGPIHDACTILYLLQ
PELFTMVPVNIDIEHQSPLTYGTMAVDLNHVTGKPANAYFATAVDVEEVW
NLIDHKLRTYE
>SAS1132 putative pyrimidine operon regulatory protein
MSERIIMDDAAIQRTVTRIAHEILEYNKGTDNLILLGIKTRGEYLANRIQ
DKIHQIEQQRIPTGTIDITYFRDDIEHMSSLTTKDAIDIDTDITDKVVII
IDDVLYTGRTVRASLDAILLNARPIKIGLAALVDRGHRELPIRADFVGKN
IPTSKEETVSVYLEEMDQRNAVIIK
>SAS1089 hypothetical protein
MKKNITKVIIASTVIATGLLTQTNDAKAFFSYEWKGLEIAKNLADQAKKD
DERADKLIKEADEKNEHYKGKTVEDLYVIAKKMGKGNTIAVVKIKDGGKN
GYYTFDITRPLEEHRKNIPVVKNGEIDSITWY
>SAS1137 putative carbamoyl-phosphate synthase, pyrimidine-specific, large chain
MPKRNDIKTILVIGSGPIIIGQAAEFDYAGTQACLALKEEGYRVILVNSN
PATIMTDKEIADKVYIEPLTHDFIARIIRKEQPDALLPTLGGQTGLNMAI
QLHESGVLQDNNVQLLGTELTSIQQAEDREMFRTLMNDLNVPVPESDIVN
TVEQAFKFKEQVGYPLIVRPAFTMGGTGGGICHNDEELHEIVSNGLHYSP
ATQCLLEKSIAGFKEIEYEVMRDKNDNAIVVCNMENIDPVGIHTGDSIVV
APSQTLSDVEYQMLRDVSLKVIRALGIEGGCNVQLALDPHSFDYYIIEVN
PRVSRSSALASKATGYPIAKLAAKIAVGLTLDEMLNPITGTSYAAFEPTL
DYVISKIPRFPFDKFEKGERELGTQMKATGEVMAIGRTYEESLLKAIRSL
EYGVHHLGLPNGESFDLDYIKERISHQDDERLFFIGEAIRRGTTLEEIHN
MTQIDYFFLHKFQNIIDIEHQLKEHQGDLEYLKYAKDYGFSDKTIAHRFN
MTEEEVYQLRMENDIKPVYKMVDTCAAEFESSTPYYYGTYETENESIVTD
KEKILVLGSGPIRIGQGVEFDYATVHAVWAIQKAGYEAIIVNNNPETVST
DFSISDKLYFEPLTEEDVMNIINLEKPKGVVVQFGGQTAINLADKLAKHG
VKILGTSLENLNRAEDRKEFEALLRKINVPQPQGKTATSPEEALANAAEI
GYPVVVRPSYVLGGRAMEIVDNDKELENYMTQAVKASPEHPVLVDRYLTG
KEIEVDAICDGETVIIPGIMEHIERAGVHSGDSIAVYPPQTLTEDELATL
EDYTIKLAKGLNIIGLINIQFVIAHDGVYVLEVNPRSSRTVPFLSKITDI
PMAQLAMRAIIGEKLTDMGYQEGVQPYAEGVFVKAPVFSFNKLKNVDITL
GPEMKSTGEVMGKDTTLEKALFKGLTGSGVEVKDHGTVLMTVSDKDKEEV
VKLAQRLNEVGYKILATSGTANKLAEYDIPAEVVGKIGGENDLLTRIQNG
DVQIVINTMTKGKEVERDGFQIRRTTVENGIPCLTSLDTANALTNVIESM
TFTMRQM
>SAS0467 putative hypoxanthine phosphoribosyltransferase
MHNDLKEVLLTEEDIQNICKELGAQLTKDYQGKPLVCVGILKGSAMFMSD
LIKRIDTHLSIDFMDVSSYHGGTESTGEVQIIKDLGSSIENKDVLIIEDI
LETGTTLKSITELLQSRKVNSLEIVTLLDKPNRRKADIEAKYVGKKIPDE
FVVGYGLDYRELYRNLPYIGTLKPEVYSN
>SAS2030 putative CTP synthase
MTKFIFVTGGVVSSLGKGITASSLGRLLKDRGLNVTIQKFDPYLNVDPGT
MSPYQHGEVFVTDDGAETDLDLGHYERFIDINLNKFSNVTAGKVYSHVLK
KERRGDYLGGTVQVIPHITNEIKERLLLAGESTNADVVITEIGGTTGDIE
SLPFIEAIRQIRSDLGRENVMYVHCTLLPYIKAAGEMKTKPTQHSVKELR
GLGIQPDLIVVRTEYEMTQDLKDKIALFCDINKESVIECRDADSLYEIPL
QLSQQNMDDIVIKRLQLNAKYETQLDEWKQLLDIVNNLDGKITIGLVGKY
VSLQDAYLSVVESLKHAGYPFAKDIDIRWIDSSEVTDENAAEYLADVDGI
LVPGGFGFRASEGKISAIKYARENNVPFFGICLGMQLATVEFSRNVLGLE
GAHSAELDPATPYPIIDLLPEQKDIEDLGGTLRLGLYPCSIKEGTLAQDV
YGKAEIEERHRHRYEFNNDYREQLEANGMVISGTSPDGRLVEMVEIPTND
FFIACQFHPEFLSRPNRPHPIFKSFIEASLKYQQNK
>SAS1133 putative uracil permease
MQNDEMFERTVKPVLDVNEKPQPAQWAFLSLQHLFAMFGATVLVPFLTGL
PISAALLASGIGTLLYILITKAQIPAYLGSSFAFITPIITGLSTHSLGDM
LVALFMSGVMYVIIGILIKLSGTAWLMKLLPPVVVGPVIMVIGLSLAPTA
VNMAMYENPGDMKGYNISFLIVAMITLLVTIVVQGFFKGFLSLIPVLVGI
IVGYVVAIFMGIVKFDAIMSAKWIDFPHIYLPFKDYVPSFHLGLVLVMIP
IVFVTVSEHIGHQMVLNKIVGRNFFEKPGLDKSIIGDGVSTMFASIIGGP
PSTTYGENIGVLAITRIYSIYVIGGAAVIAIVLAFIGKFTALISSIPTPV
MGGVSILLFGIIAASGLRMLVESKVDFANNRNLVIASVILVVGIGNLVFN
LKEIGINLQIEGMALAALSGIILNLILPKEKKQNN
>SAS1571 adenine phosphoribosyltransferase
MDLKQYVSEVQDWPKPGVSFKDITTIMDNGEAYGYATDKIVEYAKDRDVD
IVVGPEARGFIIGCPVAYSMGIGFAPVRKEGKLPREVIRYEYDLEYGTNV
LTMHKDAIKPGQRVLITDDLLATGGTIEAAIKLVEKLGGIVVGIAFIIEL
KYLNGIEKIKDYDVMSLISYDE
>SAS0119 putative nucleotidase
MSNIAFYVVSDVHGYIFPTDFTSRNQYQPMGLLLANHVIEQDRRQYDQSF
KIDNGDFLQGSPFCNYLIAHSGSSQPLVDFYNRMAFDFGTLGNHEFNYGL
PYLKDTLRRLNYPVLCANIYENDSTLTDNGVKYFQVGDQTVGVIGLTTQF
IPHWEQPEHIQSLTFHSAFEILQQYLPEMKRHADIIVVCYHGGFEKDLES
GTPTEVLTGENEGYAMLEAFSKDIDIFITGHQHRQIAERFKQTAVIQPGT
RGTTVGRVVLSTDEYENLSVESCELLPVIDDSTFTIDEDDQHLRKQLEDW
LDYEITTLPYDMTINHAFEARVAPHPFTNFMNYALLEKSDADVACTALFD
SASGFKQVVTMRDVINNYPFPNTFKVLAVSGAKLKEAIERSAEYFDVKND
EVSVSADFLGPKPQHFNYDIYGGVSYTIHVGRPKGQRVSNMMIQGHAVDL
KQTYTICVNNYRAVGGGQYDMFIDAPVVKDIQVEGAQLLIDFLSNNNLMR
IPQVVDFKVEK
>SAS1085 conserved hypothetical protein
MKEIVIASNNQGKINDFKVIFPDYHVIGISELIPDFDVEETGSTFEENAI
LKSEAAAKALNKTVIADDSGLEVFALNGEPGIYSARYAGENKSDEANIEK
LLNKLGNTTDRRAQFVCVISMSGPDMETKVFKGTVSGEIADGKYGENGFG
YDPIFYVPKLDKTMAQLSKEQKGQISHRRNAINLLQAFLEGDKNV
>SAS0439 putative thymidylate kinase
MSAFITFEGPEGSGKTTVINKVYHRLVKDYDVIMTREPGGVPTGEEIRKI
VLEGNDMDIRTEAMLFAASRREHLVLKVIPALKEGKVVLCDRYIDSSLAY
QGYARGIGVEEVRALNEFAINGLYPDLTIYLNVSAEVGRERIIKNSRDQN
RLDQEDLKFHEKVIEGYQEIIHNESQRFKSVNADQPLENVVEDTYQTIIK
YLEKI
>SAS0515 putative deoxyadenosine kinase protein
MNKPFIAIEGPIGVGKSSLAHKLSQTLDFYEEKEIITENPFLSDFYEDIS
KWSFQTEMFFLCNRYKQFQDVTQLNQGVVSDYHIHKNKIFAKNTLSSVEF
QKFSKIYDILTEDMIMPNMIIFLDADLDVLKSRIAKRNRSFEHQIEDEYL
LKLKKDYREYYESLQSNGSNVVLIDTTSIDFLKNEQDYEDILHIILPMIG
DITNE
>SAS0367 putative GMP synthase
MEMAKEQELILVLDFGSQYNQLITRRIREMGVYSELHDHEISIEEIKKMN
PKGIILSGGPNSVYEEGSFTIDPEIYNLGIPVLGICYGMQLTTKLLGGKV
ERANEREYGKAIINAKSDELFAGLPAEQTVWMSHSDKVIEIPEGFEVIAD
SPSTDYAAIEDKKRRIYGVQFHPEVRHTEYGNDLLNNFVRRVCECKGQWT
MENFIEIEIEKIRQRVGDRRVLCAMSGGVDSSVVAVLLHKAIGDQLTCIF
VDHGLLRKGEGDMVMEQFGEGFNMNIIRVNAKDRFMNKLKGVSDPEQKRK
IIGNEFVYVFDDEASKLKGVDFLAQGTLYTDVIESGTKTAQTIKSHHNVG
GLPEDMEFELIEPINTLFKDEVRKLGIELGIPEHLVWRQPFPGPGLGIRV
LGEITEDKLEIVRESDAILRQVIREEGLEREIWQYFTVLPNIQSVGVMGD
YRTYDHTVGIRAVTSIDGMTSDFARIDWEVLQKISSRIVNEVDHVNRVVY
DITSKPPSTIEWE
>SAS1008 putative phosphoribosylglycinamide formyltransferase
MVKIAIFASGSGSNFENIVEHVESGKLENIEVTALYTDHQNAFCIDRAKK
HDIPVYINEPKQFDSKAAYEQHLVSLLNEDKVEWIILAGYMRLIGPDLLA
SFEGKILNIHPSLLPKYKGIDAIGQAYHSGDTITGSTVHYVDCGMDTGEI
IEQRQCDIRPDDSKEQLEEKVKKLEYELYPSVIAKIVK
>SAS0290 putative nucleoside permease
MNILFAITGIAFALFVAFLFSFDRKNIDFKKTLIMIFIQVLIVLFMMNTT
IGLTILTALGSFFEGLINVSKAGINFVFGDIQNKNGFTFFLNVLLPLVFI
SVLIGIFNYIKVLPFIIKYVGIAINKITRMGRLESYFAISTAMFGQPEVY
LTIKDIIPRLSRAKLYTIATSGMSAVSMAMLGSYMQMIEPKFVVTAVMLN
IFSALIIASVINPYKSDDSDVEIDNLTKSTETKSVNGKTGKPKKVAFFQM
IGDSAMDGFKIAVVVAVMLLAFISLMEAINIMFGSVGLNFKQLIGYVFAP
IAFLMGIPWSEAVPAGSLMATKLITNEFVAMLDFKNVLGDVSARTQGIIS
VYLVSFANFGTVGIIVGSIKGISDKQGEKVASFAMRLLLGSTLASIISGS
IIGLVL
>SAS1001 putative phosphoribosylaminoimidazole carboxylase ATPase subunit
MSFNKLKFGATIGIIGGGQLGKMMAQSAQKMGYKVVVLDPSEDCPCRYVA
HEFIQAKYDDEKALNQLGQKCDVITYEFENISAQQLKLLCEKYNIPQGYQ
AIQLLQDRLTEKETLKSAGTKVVPFISVKESTDIDKAIETLGYPFIVKTR
FGGYDGKGQVLINNEKDLQEGFKLIETSECVAEKYLNIKKEVSLTVTRGN
NNQITFFPLQENEHRNQILFKTIVPARIDKTAEAKEQVNKIIQSIHFIGT
FTVEFFIDSNNQLYVNEIAPRPHNSGHYSIEACDYSQFDTHILAVTGQSL
PNSIELLKPAVMMNLLGKDLDLLENEFNEHPEWHLHIYGKSERKDSRKMG
HMTVLTNDVNQTEQDMYAKFEGSN
>SAS1135 putative dihydroorotase
MKLIKNGKVLQNGELQQADILIDGKVIKQIAPAIEPSNGVDIIDAKGHFV
SPGFVDVHVHLREPGGEYKETIETGTKAAARGGFTTVCPMPNTRPVPDSV
EHFEALQKLIDDNAQVRVLPYASITTRQLGKELVDFPALVKEGAFAFTDD
GVGVQTASMMYEGMIEAAKVNKAIVAHCEDNSLIYGGAMHEGKRSKELGI
PGIPNICESVQIARDVLLAEAAGCHYHVCHVSTKESVRVIRDAKRAGIHV
TAEVTPHHLLLTEDDIPGNNAIYKMNPPLRSTEDREALLEGLLDGTIDCI
ATDHAPHARDEKAQPMEKAPFGIVGSETAFPLLYTHFVKNGDWTLQQLVD
YLTIKPCETFNLEYGTLKENGYADLTIIDLDSEQEIKGEDFLSKADNTPF
IGYKVYGNPILTMVEGEVKFEGDK
>SAS2040 putative deoxyribose-phosphate aldolase
MHSAKLIDHTLLKPESTRTQIDQIIDEAKAYHFKSVCVNPTHVKYAAERL
ADSEVLVCTVIGFPLGASTTATKAFETEDAIQNGADEIDMVINIGALKDG
RFDDVQQDIEAVVKAAKGHTVKVIIETVLLDHDEIVKASELTKAAGADFV
KTSTGFAGGGATAEDVKLMKDTVGADVEVKASGGVRNLEDFNKMVEAGAT
RIGASAGVQIMQGLEADSDY
>SAS1526 putative deaminase
MERIKWEEYFMAQSHLLALRSTCQRLSVGATIVKDNRIIAGGYNGSVAGE
VHCIDEGCLIEDGHCIRTIHAEMNALLQCAKQGVSTEGATIYVTHFPCLN
CTKSIIQAGIKRIYYAEDYHNHEYATKLLKQSGIEFKKIPFSPEYVAKYL
TKG
>SAS0697 ribonucleoside-diphosphate reductase beta chain
MIAVNWNTQEDMTNMFWRQNISQMWVETEFKVSKDIASWKTLSEAEQDTF
KKALAGLTGLDTHQADDGMPLVMLHTTDLRKKAVYSFMAMMEQIHAKSYS
HIFTTLLPSSETNYLLDEWVLEEPHLKYKSDKIVANYHKLWGKEASIYDQ
YMARVTSVFLETFLFFSGFYYPLYLAGQGKMTTSGEIIRKILLDESIHGV
FTGLDAQHLRNELSESEKQKADQEMYKLLNDLYLNEESYTKMLYDDLGIT
EDVLNYVKYNGNKALSNLGFEPYFEEREFNPIIENALDTTTKNHDFFSVK
GDGYVLALNVEALQDDDFVFDNK
>SAS1005 putative phosphoribosylformylglycinamidine synthase II
MSKFIEPSVEEIKLEKVYQDMGLSDQEYEKVCDILGRQPNFTETGIFSVM
WSEHCSYKHSKPFLKQFPTSGDHVLMGPGEGAGVVDIGDNQAVVFKVESH
NHPSAIEPYQGAATGVGGIIRDIVSIGARPINLLNSLRFGELDNKQNQRL
LKGVVKGIGGYGNCIGIPTTAGEIEFDERYDGNPLVNAMCVGVINHDMIQ
KGTAKGVGNSVIYVGLKTGRDGIHGATFASEELTEESESKRPSVQIGDPF
VGKKLMEATLEAITFDELVGIQDMGAAGLTSSSSEMAAKGGSGLHLRLEQ
VPTREPGISPYEMMLSETQERMLLVVEKGTEQKFLDLFDKHELDSAVIGE
VTDTNRFVLTYDDEVYADIPVEPLADEAPVYILEGEEKDYNTSKNDYTHI
DVKDTFFKLLKHPTIASKHYLYDQYDQQVGANTIIKPGLQASVVRVEGTN
KAIASTIDGEARYVYNNPYEGGKMVVAEAYRNLIAVGATPLAMTDCLNYG
SPEKKEIYQQLIDSTKGMAEACDILKTPVVSGNVSLYNETKGTSIFPTPV
VGMVGLIENVNYLNDFEPQVGDKLYLIGDTKDDFGGSQLEKLIYGKVNHE
FESLDLSSEVEKGESIKTAIREGLLSHVQTVGKGGLLITLAKLSAHYGLG
LKSSIDITNAQLFSETQGRYVVSVKSGKTLNIDNAIEIGLLTDSDNFKVT
TPYTEISENVSDIKQIWEGAIAQCLTTQD
>SAS0695 conserved hypothetical protein
MKIIYFSFTGNVRRFIKRTELENTLEITAENCMEPVHEPFIIVTGTIGFG
EVPEPVQSFLEVNHQYIRGVAASGNRNWGLNFAKAGRTISEEYNVPLLMK
FELHGKNKDVIEFKNKVGNFNENHGREKVQSY
>SAS2035 hypothetical protein
MTNNGNEPNLTLSDLYDKDVVYTSRPSYISNPWLKPDEHQSNFLTGRELL
IANQLPVIVHEASATDKLHQLFQVIGKEVPNSIYTFNNQQSYENLIKQLA
HKENKKIYFQYIHDETILNQQYYALDKTLFVALNNKARIPEWTNGKFLPK
RKVVKIEQFENEIKNWEFPLVIKPGDDLPTAGGYGVMICYHDADLQKAIT
RIKEATAETNSLIIEQKIEEKANYCVQFAYSESLGIQYLGAATQLTDKYG
FYNGNENTTNVPEHVIEAGRQIMENGVNQGFFGVAGFDLLVDEDDNVYAI
DLNFRQNGSTSMLLLANELNSGYQKFYSYHSKGDNTHFFNTILKYVKEGS
LYPLSYYDGDWYGEDKVKSRFGCIWHGDSKETVLENERAFLAELEHY
>SAS0099 putative membrane protein
MSSIIGKIAIWIGIVAQIYFSVVFVRMISINIAGGSDYETIFLLGLILAL
FTVLPTIFTAIYMESYSVIGGALFIVYAIIALCLYNFFSSILWLIGGILL
IWNKYSKDESTDENEKVDIESTENQFESKDKITKE
>SAS2041 putative purine nucleoside phosphorylase
MTKGTPHIQPNGVKIAKTVLMPGDPLRAKYIADNFLENVEQFNDVRNMFG
YTGTYKGKEVSVMGSGMGIPSIGIYSYELYNFFDVDTIIRIGSCGALQEN
VNLYDVIIAQAASTNSNYVDQYNIPGHFAPIADFELVTKAKNVADQIGAT
THVGNVLSSDTFYNADPTFNDAWKKMGILGIEMESAGLYLNAIHAGKKAL
GIFTVSDHILRDEATTPEERQNSFTQMMEIALEIAE
>SAS1547 uridine kinase
MKATTIIGIAGGSGSGKTTVTNEIMKNLEGHSVALLAQDYYYKDQKHLTF
DERLETNYDHPFAFDNDLLIENLKDLKNGKAVEVPTYDYASHTRSDITID
FKPKDVIIVEGIFALENKVLRDMMDVKIYVDTDADLRILRRLTRDTKERG
RSMDSVINQYLSVVRPMHDQFIEPTKKYADIIIPEGGSNKVAIDIMTTKI
QSLVSKQ
>SAS2039 putative pyrimidine-nucleoside phosphorylase
MRMIDIIEKKRDGHTLTTEEINFFIDGYVKGDIPDYQASSLAMAIYFQDM
NDDERAALTMAMVNSGDMIDLSDIKGVKVDKHSTGGVGDTTTLVLAPLVA
AVDVPVAKMSGRGLGHTGGTIDKLEAIDGFHVEIDEATFVKLVNENKVAV
VGQSGNLTPADKKLYALRDVTGTVNSIPLIASSIMSKKIAAGADAIVLDV
KTGSGAFMKTLEDAEALAHAMVRIGNNVGRNTMAIISDMNQPLGRAIGNA
LELQEAIDTLKGQGPKDLTELVLTLGSQMVVLANKAETLEEARALLIEAI
NSGAALEKFKTFIKNQGGDETVIDHPERLPQAQYQIEYKAKKSGYVTELV
SNDIGVASMMLGAGRLTKEDDIDLAVGIVLNKKIGDKVEEGESLLTIHSN
RQDVDDVVKKLDSSITIADHVVSPTLIHKIIIE
>SAS1002 putative phosphoribosylaminoimidazole-succinocarboxamide synthase
MTLLYEGKAKRIFSTNQENELRVEYKDEVTAGNGAKKDTMAGKGRLNNQI
TSIIFKYLQENGIESHFIKQLSETEQLVKPVKIIPLEVVVRNIASGSITK
RLGFENGEVFREPLVEFFYKNDALNDPLITDDHVKLLNIASDEDIEILKS
KALKINNVLKQLMDAMNLKLVDFKIEFGKTETGQILLADEISPDTCRIWD
KATNANFDKDVYRNNTGSLIETYQIFLNKLEDLK
>SAS1831 adenylosuccinate lyase
MIERYSREEMSNIWTDQNRYEAWLEVEILACEAWSELGHIPKADVQKIRQ
NAKVNVERAQEIEQETRHDVVAFTRQVSETLGEERKWVHYGLTSTDVVDT
ALSFVIKQANDIIEKDLERFIDVLAEKAKNYKYTLMMGRTHGVHAEPTTF
GVKMALWYTEMQRNLQRFKQVREEIEVGKMSGAVGTFANIPPEIESYVCK
HLGIGTAPVSTQTLQRDRHAYYIATLALIATSLEKFAVEIRNLQKTETRE
VEEAFAKGQKGSSAMPHKRNPIGSENITGISRVIRGYITTAYENVPLWHE
RDISHSSAERIMLPDVTIALDYALNRFTNIVDRLTVFEDNMRNNIDKTFG
LIFSQRVLLALINKGMVREEAYDKVQPKAMISWETKTPFRELIEQDESIT
SVLTKEELDECFDPKHHLNQVDTIFERAGLA
>SAS0610 putative Na+ dependent nucleoside transporter
MFLLINIIGLIVFLGIAVLFSRDRKNIQWQSIGILVVLNLFLAWFFIYFD
WGQKAVRGAANGIAWVVQSAHAGTGFAFASLTNVKMMDMAVAALFPILLI
VPLFDILMYFNILPKIIGGIGWLLAKVTRQPKFESFFGIEMMFLGNTEAL
AVSSEQLKRMNEMRVLTIAMMSMSSVSGAIVGAYVQMVPGELVLTAIPLN
IVNAIIVSCLLNPVSVEEKEDIIYSLKNNEVERQPFFSFLGDSVLAAGKL
VLIIIAFVISFVALADLFDRFINLITGMIAGWIGIKGSFGLNQILGVFMY
PFALLLGLPYDEAWLVAQQMAKKIVTNEFVVMGEISKDIASYTPHHRAVI
TTFLISFANFSTIGMIIGTLKGIVDKKTSDFVSKYVPMMLLSGILVSLLT
AAFVGLFAW
>SAS1007 putative phosphoribosylformylglycinamidine cyclo-ligase
MSKAYEQSGVNIHAGYEAVERMSSHVKRTMRKEVIGGLGGFGATFDLSQL
NMTAPVLVSGTDGVGTKLKLAIDYGKHDSIGIDAVAMCVNDILTTGAEPL
YFLDYIATNKVVPEVIEQIVKGISDACVETNTALIGGETAEMGEMYHEGE
YDVAGFAVGAVEKDDYVDSSEVKEGQVVIGLASSGIHSNGYSLVRKLINE
SGIDLASNFDNRPFIDVFLEPTKLYVKPVLALKKEVSIKAMNHITGGGFY
ENIPRALPAGYAARIDTTSFPTPKIFDWLQQQGNIDTNEMYNIFNMGIGY
TVIVDEKDASRALKILAEQNVEAYQIGHIMKNESTAIELLGV
>SAS1658 formate--tetrahydrofolate ligase
MTHLSDLDIANQSTLQPIKDIAASVGISEDALEPYGHYKAKIDINKITPR
ENKGKVVLVTAMSPTPAGEGKSTVTVGLADAFHELNKNVMVALREPALGP
TFGIKGGATGGGYAQVLPMEDINLHFNGDFHAITTANNALSAFIDNHIHQ
GNELGIDQRRIEWKRVLDMNDRALRHVNVGLGGPTNGVPREDGFNITVAS
EIMAILCLSRSIKDLKDKISRITIGYTRDRKPVTVADLKVQGALAMILKD
AIKPNLVQSIEGTPALVHGGPFANIAHGCNSILATETARDLADIVVTEAG
FGSDLGAEKFMDIKAREAGFDPAAVVVVATIRALKMHGGVAKDNLKEENV
EAVKAGIVNLERHVNNIKKFGVEPVVAINAFIHDTDAEVEYVKSWAKENN
VRIALTEVWEKGGKGGVDLANEVLEVIDQPNSFKPLYELELPLEQKIEKI
VTEIYGGSKVTFSSKAQKQLKQFKENGWDNYPVCMAKTQYSFSDDQTLLG
APSGFEITIRELEAKTGAGFIVALTGAIMTMPGLPKKPAALNMDVTDDGH
AIGLF
>SAS1506 cytidine deaminase
MSYQPHYFQEVRKAQQESYSPYSQFKVGAYLKTKDGRTFYGTNVENASYP
LSICAERASLVSAISQGYRPGDFESITVTVDADKPSSPCGACRQVLKELC
DDDMPVYMTNHKGDMVMMTVAELLPFGFSGKDLE
>SAS2022 putative thymidine kinase
MYETYHSGWIECITGSMFSGKSEELIRRLRRGIYAKQKVVVFKPAIDDRY
HKEKVVSHNGNAIEAINISKASEIMTHDLTNVDVIGIDEVQFFDDEIVSI
VEKLSADGHRVIVAGLDMDFRGEPFEPMPKLMAVSEQVTKLQAVCAVCGS
SSSRTQRLINGKPAKIDDPIILVGANESYEPRCRAHHIVAPSDNNKEEL
>SAS1418 cytidylate kinase
MKAINIALDGPAAAGKSTIAKRVASELSMIYVDTGAMYRALTYKYLKLNK
TEDFAKLVDQTTLDLTYKADKGQCVILDNEDVTDFLRNNDVTQHVSYVAS
KEPVRSFAVKKQKELAAEKGIVMDGRDIGTVVLPDADLKVYMIASVEERA
ERRYKDNQLRGIESNFEDLKRDIEARDQYDMNREISPLRKADDAVTLDTT
GKSIEEVTDEILAMVSQIK
>SAS0514 putative deoxyadenosine kinase protein
MNNYGIPQNAIITIAGTVGVGKSTLTQALADKLNFKTSFENVEHNPYLDK
FYSDFERWSFHLQIYFLAERFKEQKRMFEYGGGFVQDRSIYEDVDIFAKM
HEEEGTMSKEDFKTYSDLFNAMVMTPYFPKPDVMIYLECNYDEVIDRIIE
RGREMEINTDPEYWKKLFKRYDDWINSFNACPVVRININEYDIHKDPESL
NPMIDKIARIIQTYRQVDTR
>SAS1536 5'-methylthioadenosine/S-adenosylhomocysteinenuc leosidase
MIGIIGAMEEEVTILKNKLTQLSEISVAHVKFYTGILKDREVVITQSGIG
KVNAAISTTLLINKFKPDVIINTGSAGALDESLNVGDVLISDDVKYHDAD
ATAFGYEYGQIPQMPVAFQSSKPLIEKVSQVVQQQQLTAKVGLIVSGDSF
IGSVEQRQKIKKAFPNAMAVEMEATAIAQTCYQFNVPFVVVRAVSDLANG
EAEMSFEAFLEKAAVSSSQTVEALVSQL
>SAS1010 putative phosphoribosylamine--glycine ligase
MNVLVIGAGGREHALAYKLNQSNLVKQVFAIPGNEAMTPIAEVHTEISES
DHQAILDFAKRQNVDWVVIGPEQPLIDGLADILRANGFKVFGPNKQAAQI
EGSKLFAKKIMEKYNIPTADYKEVERKKDALTYIENCELPVVVKKDGLAA
GKGVIIADTIEAARSAIEIMYGDEEEGTVVFETFLEGEEFSLMTFVNGDL
AVPFDCIAQDHKRAFDHDEGPNTGGMGAYCPVPHISDDVLKLTNETIAQP
IAKAMLNEGYQFFGVLYIGAILTKNGPKVIEFNARFGDPEAQVLLSRMES
DLMQHIIDLDEGKRTEFKWKNESIVGVMLASKGYPDAYEKGHKVSGFDLN
ENYFVSGLKKQGDTFVTSGGRVILAIGKGDNVQDAQRDAYEKVSQIQSDH
LFYRHDIANKALQLK
>SAS1009 putative bifunctional purine biosynthesis protein [includes: phosphoribosylaminoimidazolecarboxamide formyltransferase and IMP cyclohydrolase]
MKKAILSVSNKTGIVEFAKALTQLNYELYSTGGTKRILDEANVPVRSVSD
LTHFPEIMDGRVKTLHPAVHGGILADRNKPQHLNELSEQHIDLIDMVVVN
LYPFQQTVANPDVTMDEAIENIDIGGPTMLRAAAKNYKHVTTIVHPADYQ
EVLTRLRNDSLDESYRQSLMIKVFEHTAEYDEAIVRFFKGDKETLRYGEN
PQQSAYFVRTSNAKHTIAGAKQLHGKQLSYNNIKDADATLALVKKFDTPA
TVAVKHMNPCGVGIGDTIEQAFQHAYEADSQSIFGGIVALNRAVTPELAE
QLHSIFLEVIIAPKFTDEALDILKQKKNVRLLEIDMTIDSNEEEFVSVSG
GYLVQDKDNYVVPKEEMKVVTEVAPTDEQWEAMLLGWKVVPSVKSNAIIL
SNNKQTVGIGAGQMNRVGAAKIALERAIEINDHVALVSDGFFPMGDTVEL
AAQHGIKAIIQPGGSIKDQDSIDMANKHGIAMVVTGTRHFKH
>SAS0365 putative xanthine permease
MKNLILSVQHLLAMYAGAILVPIIVGTSLKFTPEQIAYLVTVDIFMCGVA
TFLQANKVTGTGLPIVLGCTFTAVAPMILIGQTKGIDVLYGSLFLSGILV
IIIAPFFSHLVKFFPPVVTGSVVTIIGINLMPVAMNYLAGGQGAKDYGDV
KNILLGLMTLIIILVLQRFTTGFIKSIAILIGLVLGTIGAGLLGMVDINQ
VNHAGWLGIPVPFRFSGFSFDVTSTLVFFIVAIVSLIESTGVYHALSEIT
GKKLERKDFRKGYTAEGLAIVLGSIFNSFPYTAYSQNVGLVSLSGAKKNN
VIYGMVVLLLICGCIPKLGALANIIPLPVLGGAMIAMFGMVMAYGVSILG
HIDFKNQNNLLIIAVSVGLGTGISAVPQAFKGLGEQFAWLTQNGIVLGAI
SAIILNFFFNGIKYKQTEENVK
>SAS1006 putative amidophosphoribosyltransferase precursor
MFNYSGLNEECGVFGIWNHPEAAQLTYMGLHSLQHRGQEGAGIVVSDQNE
LKGERGLGLLTEAIKDDQMERLKGYQHAIGHVRYATSGNKGIENIQPFLY
HFYDMSVGICHNGNLINAKSLRQNLEKQGAIFHSSSDTEVIMHLIRRSKA
PTFEEALKESLRKVKGGFTFAILTKDALYGAVDPNAIRPLVVGKMKDGTY
ILASETCAIDVLGAEFVQDIHAGEYVVINDKGITVKSYTHHTTTAISAME
YIYFARPDSTIAGKNVHAVRKASGKKLAQESPVNADMVIGVPNSSLSAAS
GYAEEIGLPYEMGLVKNQYVARTFIQPTQELREQGVRVKLSAVKDIVDGK
NIILVDDSIVRGTTIRRIVKMLKDSGANKVHVRIASPEFMFPSFYGIDVS
TTAELISASKSPEEIKDYIGADSLAYLSVDGLIESIGLDYDAPYSGLCVE
SFTGDYPAGLYDYEANYKAHLSHRQKQYISKNKHFFDSEGNLNV
>SAS0017 putative adenylosuccinate synthetase
MSSIVVVGTQWGDEGKGKITDFLAEQSDVIARFSGGNNAGHTIQFGGETY
KLHLVPSGIFYKDKLAVIGNGVVVDPVALLKELDGLNERGIPTSNLRISN
RAQVILPYHLAQDEYEERLRGDNKIGTTKKGIGPAYVDKVQRIGIRMADL
LEKETFERLLKSNIEYKQAYFKGMFNETCPSFDDIFEEYYAAGQRLKEFV
TDTSKILDDAFVADEKVLFEGAQGVMLDIDHGTYPFVTSSNPIAGNVTVG
TGVGPTFVSKVIGVCKAYTSRVGDGPFPTELFDEDGHHIREVGREYGTTT
GRPRRVGWFDSVVLRHSRRVSGITDLSINSIDVLTGLDTVKICTAYELDG
KEITEYPANLDQLKRCKPIFEELPGWTEDVTNVRTLEELPENARKYLERI
SELCNVQISIFSVGPDREQTNLLKELW
>SAS0794 putative 5'-nucleotidase
MRLTIYHTNDIHSHLHEYERIKAYMAEHRPRLNHPSLYVDLGDHVDLSAP
ITEATLGKKNVALLNEAKCDVATIGNNEGMTISHEALNHLYDEAKFIVTC
SNVIDESGHLPNNIVSSYIKDIDGVKILFVAATAPFTPFYRALNWIVTDP
LESIKEEIELQRGKFDVLIVLSHCGIFFDETLCQELPEIDVIFGSHTHHY
FEHGEINNGVLMAAAGKYGNYLGEVNLTFEAHKVVHKTAKIIPLKTLPEV
ETSFEEEGKTLMSNSVIQHPVVLKRSMNHITEAAYLLAQSVCEYTHAQCA
IINAGLLVKDIVKDEVTEYDIHQMLPHPINMVRVRLFGVKLKEIIAKSNK
QEYMYEHAQGLGFRGNIFGGYILYNLGYIHSTGRYYLNGEEIEDDKEYVL
GTIDMYTFGRYFPTLKELPKEYLMPEFLRDIFKEKLLEY
>SAS1134 putative aspartate carbamoyltransferase
MNHLLSMEHLSTDQIYKLIQKASQFKSGERQLPNFEGKYVANLFFENSTR
TKCSFEMAELKLGLKTISFETSTSSVSKGESLYDTCKTLESIGCDLLVIR
HPFNNYYEKLANINIPIANAGDGSGQHPTQSLLDLMTIYEEYGYFEGLNV
LICGDIKNSRVARSNYHSLKALGANVMFNSPNAWIDDSLEAPYVNIDDVI
ETVDIVMLLRIQHERHGLAEETRFAADDYHQKHGLNEVRYNKLQEHAIVM
HPAPVNRGVEIQSDLVEASKSRIFKQMENGVYLRMAVIDELLK
>SAS0516 putative deaminase
MTNDIYFMTLAIEEAKKAAQLGEVPIGAIITKDDEVIARAHNLRETLQQP
TAHAEHIAIERAAKVLGSWRLEGCTLYVTLEPCVMCAGTIVMSRIPRVVY
GADDPKGGCSGSLMNLLQQSNFNHRAIVDKGVLKEACSTLLTTFFKNLRA
NKKSTN
>SAS2475 putative dihydroorotate dehydrogenase
MYKLIKPFLFKIEPEKAHGLTIDALKTLQKFPVLFPVVDKLFTYKNPTLS
QTIQGNTYDNPIGLAAGFDKSCEVPKALEHLGFGALELGGITPKPQPGNP
QPRMFRLLEDDALINRMGFNNIGMNKALSHLRKNAYQVPVGINVGVNKMT
PYEARYQDYIKVIDTFKHDVSFFTVNISSPNTENLQNFHDKDEFSMLCQA
LTTFKKQHDVTVPIYLKLTSDMDFDGLKALLPAITETFDGIILANTTRQR
DGLTSANKVEEGGLSGRPLFERNLKLIKYAYQQTNGEFLIIGTGGVFSTE
DAIKMMRHGASLIQIYSSLVIEGPGLTKKMNKGIARYLKDHHFDNVSDII
GLDA
>SAS2536 hypothetical protein
MLKNKTFKVTWNYISQTTFMYGSKVSFSNGEVTFINPLMPSGLPIHEWLM
LKQFSKYKSAPSLPILRRGQHYKLHFDFDATPAGSVYFIIIFYNKNGTKL
STEIVKSNSITIQYPDEAYAYKIKMMNAASTSLVFRCLTITEMTHQDDLE
YKSMRVTKIDDNQYGNDKINVIIAEPSDVYPTISNDFLKLFGHVWLVERW
MEDDIKENIKQLKDDLQSQDTLTAINLISYGSKSNVFATYVAQHLDCKVY
RTSHEDDDLKEWLKEHVPGNHELKDTNVEVYFKEEQDNHLNYMSRLMNPV
RFLDYLDVSKLNGGEVNET
>SAS1410 putative nucleoside diphosphate kinase
MERTFLMIKPDAVQRNLIGEVISRIERKGLKLVGGKLMQVPMELAETHYG
EHQGKPFYNDLISFITSAPVFAMVVEGEDAVNVSRHIIGSTNPSEASPGS
IRGDLGLTVGRNIIHGSDSLDSAEREINLWFNENEITSYASPRDAWLYE
>SAS1139 putative orotate phosphoribosyltransferase
MAKEIAKSLLDIEAVTLSPNDLYTWSSGIKSPIYCDNRVTLGYPLVRGAI
RDGLINLIKEHFPEVEVISGTATAGIPHAAFIAEKLKLPMNYVRSSNKSH
GKQNQIEGAKSEGKKVVVIEDLISTGGSSVTAVEALKLAGAEVLGVVAIF
TYGLKKADDTFSNIQLPFYTLSDYSELIEVAENEGKISSEDIQTLVEWRD
NLA
>SAS1192 putative uridylate kinase
MAQISKYKRVVLKLSGEALAGEKGFGINPVIIKSVAEQVAEVAKMDCEIA
VIVGGGNIWRGKTGSDLGMDRGTADYMGMLATVMNALALQDSLEQLDCDT
RVLTSIEMKQVAEPYIRRRAIRHLEKKRVVIFAAGIGNPYFSTDTTAALR
AAEVEADVILMGKNNVDGVYSADPKVNKDAVKYEHLTHIQMLQEGLQVMD
STASSFCMDNNIPLTVFSIMEEGNIKRAVMGEKIGTLITK
>SAS2173 putative inosine-uridine preferring nucleoside hydrolase
MTKKVYFNHDGGVDDLVSLFLLLQMENVQLIGVSTIGADCYLEPSLSASV
KIINRFSNEDIQVAPSYERGKNPFPKEWRMHAFFMDALPILNEPVKHVAS
NVSDKEAFEDIIQTLKRQSEKVTLLFTGPLTDLAKALQKDSSIVQYIEKL
VWMGGTFLPKGNVEEPEHDGSAEWNAYWDPEAVKIVFDSDIEIDMVALES
TNQVPLTLDVRQRWANERQYTGIDFLGVSYAAVPPLTHFITNSTYFLWDV
LTTAYIGNKDLVHSIEKKVDVISYGPSQGKTFECKDGRKINVINHVDNNA
FFDYITALAKKVN
>SAS0478 nucleoside permease
MHILIGIIGIIFFLALAFLFSSDRKNIRWKYVGILLAIQLIFAFILLKTT
MGIKVIGGISNGFNYLLLKAADGVNFVFGGIQYIDPKQPPFFFSVLLPIV
FISAIIGILQYTKILPLIINVLGFLISKINGMGRLESYNAVAAAILGQSE
VFISIKKQLPYIPKQRLYTLTASAMSTVSASIIGAYFTLIEPKYVVTAVV
LNLFGGFIIASIINPYKVNEEDDKLLVEETEERQQSFFEMLGEYILDGFK
VAVIVGAMLIGYIAIIALLNGIVSNIFSTVSGGAISWDFQTLIGFVFAPF
AFLVGVPWQDAVQAGSVMATKLLSNEFVAMQALGKLSDLSEHAKGVTSVF
LVSFANFSSIGIISGAIKSLNDKKGDTVARFGLKLLFGATLVSFISAAIA
GFFI
>SAS1138 putative orotidine 5'-phosphate decarboxylase
MMKDLPIIALDFESKEKVNQFLDLFDESLFVKVGMELFYQEGPQLINEIK
ERGHDVFLDLKLHDIPNTVGKAMEGLAKLNVDLVNVHAAGGVKMMSEAIK
GLRKHNQHTKIIAVTQLTSTTEDMLRHEQNIQTSIEEAVLNYAKLANAAG
LDGVVCSPLESRMLTEKLGTSFLKVTPGIRPKGASQDDQHRITTPEEARQ
LGSTHIVVGRPITQSDNPVESYHKIKESWLV
>SAS0453 putative pur operon repressor
MRYKRSERIVFMTQYLMNHPNKLIPLTFFVKKFKQAKSSISEDVQIIKNT
FQKEKLGTVITTAGASGGVTYKPMMSKEEATEVVNEVITLLEEKERLLPG
GYLFLSDLVGNPSLLNKVGKLIASIYMEEKLDAVVTIATKGISLANAVAN
ILNLPVVVIRKDNKVTEGSTVSINYVSGSSRKIETMVLSKRTLAENSNVL
VVDDFMRAGGSINGVMNLMNEFKAHVKGVSVLVESKEVKQRLIEDYTSLV
KLSDVDEYNQEFNVEPGNSLSKFS
>SAS2120 adenylate kinase
MNIILMGLPGAGKGTQASEIVKKFPIPHISTGDMFRKAIKEETELGKEAK
SYMDRGELVPDEVTVGIVKERISEDDAKKGFLLDGFPRTIEQAEALNNIM
SELDRNIDAVINIEVPEEELMNRLTGRRICESCGTTYHLVFNPPKVEGIC
DIDGGKLYQREDDNPETVANRLSVNIKQSKPILDFYDQKGVLKNIDGSKD
ISDVTKDVIDILDHL
>SAS2015 uracil phosphoribosyltransferase
MSKVHVFDHPLIQHKLSYIRDVNTGTKEFRELVDEVGMLMAYEVTRDLEL
QDVDIETPVTKMTAKRLAGKKLAIVPILRAGLGMTDGILSLVPAARVGHI
GLYRDPETLKAVEYFAKLPQDITERQIIVVDPMLATGASAIEAITSLKKR
GAKNIRFMCLIAAPEGVEKMHEAHPDVDIYIAALDEKLNDKAYITPGLGD
AGDRLFGTK
>SAS1136 putative carbamoyl-phosphate synthase, pyrimidine-specific, small chain
MQSKRYLVLEDGSFYEGYRLGSDNLTVGEIVFNTAMTGYQETISDPSYTG
QIITFTYPLIGNYGINRDDFESLVPTLNGIVVKEASAHPSNFRQQKTLHD
VLELHQIPGIAGVDTRSITRKIRQHGVLKAGFTDRKEDIDQLVKHLQQVE
LPKNEVEIVSTKTPYVSTGKDLSVVLVDFGKKQNIVRELNVRGCNVTVVP
YTTTAEEILAMAPDGVMLSNGPGNPEVVECAIPMIQGILGKIPFFGICLG
HQLFALSQGASSFKMKFGHRGANHPVKNLETGKVDITSQNHGYAIDIDSL
KSTDLEVTHLALNDGTVEGLKHKTLPAFSVQYHPEANPGPSDSNYLFDDF
VAMMTNFKEKERHINA
>SAS0957 putative 5'-nucleotidase
MMEKNENINVEILTTSDMHSHFLNGDYGSNIYRAGTYVNQVRAQNHRVIL
LDSGGSLAGSLAAYYYAIVAPYKRHPMIKLMNRMHYDASGVSPSEFKFGL
SFLTRSIALARFPWLSANIEYNVTKEPYFSTPYCIKHFGDLKIAIVGVTA
DGLMENEYSEMEQDVSIEKTLVASKRWIRYIHEVEEPDFLIVIYHGGLNK
ISNSTKNKKASSNEAEKLMEELGVIDLMITAHQHQTIVGQDHETYYVQAG
QDAKELVHLSINFKKRTTTYDVESIDSKVIDLNEYEEDQELLDLTFYDRK
AVAYWSQEIISDKGLMLSVNGLQDLVCQTHPFSQLLHDAIHLAFDDDITC
VHVPMNGEKGLSGQIRNEDLYHAYPYPDKPMDMTISGQNIKDILEYSYSH
LDFVNEQLSLTIIDETLCTMWQGFNYEIDMNQEPGQRVMLDQIDLSKSYR
VTMTDYCYRNYKNYLKNAIIHESYDETMSTLIAEKLRDPNYHISCSDNFI
VKNR
>SAS1370 thymidylate synthase
MLNSFDAAYHSLCEEVLEIGNTRNDRTNTGTISKFGHQLRFDLSKGFPLL
TTKKVSFKLVATELLWFIKGDTNIQYLLKYNNNIWNEWAFENYIKSDEYN
GPDMTDFGHRALSDPEFNEQYKEQMKQFKQRILEDDTFAKQFGDLGNVYG
KQWRDWVDKDGNHFDQLKTVIEQIKHNPDSRRHIVSAWNPTEIDTMALPP
CHTMFQFYVQDGKLSCQLYQRSADIFLGVPFNIASYALLTHLIAKECGLE
VGEFVHTFGDAHIYSNHIDAIQTQLARESFNPPTLKINSDKSIFDINYED
LEIVDYESHPAIKAPIAV